These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 21845054)

  • 1. Current and emerging treatments for the management of myasthenia gravis.
    Sathasivam S
    Ther Clin Risk Manag; 2011; 7():313-23. PubMed ID: 21845054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance immunosuppression in myasthenia gravis.
    Gotterer L; Li Y
    J Neurol Sci; 2016 Oct; 369():294-302. PubMed ID: 27653912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance immunosuppression in myasthenia gravis, an update.
    Morren J; Li Y
    J Neurol Sci; 2020 Mar; 410():116648. PubMed ID: 31901719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic options in autoimmune myasthenia gravis.
    García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R
    Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune Myasthenia Gravis: Recommendations for Treatment and Immunologic Modulation.
    Juel VC; Massey JM
    Curr Treat Options Neurol; 2005 Jan; 7(1):3-14. PubMed ID: 15610702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenia gravis: an update for the clinician.
    Sieb JP
    Clin Exp Immunol; 2014 Mar; 175(3):408-18. PubMed ID: 24117026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis: options and timing of immunomodulatory treatment.
    Spring PJ; Spies JM
    BioDrugs; 2001; 15(3):173-83. PubMed ID: 11437683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment-refractory myasthenia gravis.
    Silvestri NJ; Wolfe GI
    J Clin Neuromuscul Dis; 2014 Jun; 15(4):167-78. PubMed ID: 24872217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, lambert-eaton myasthenic syndrome, and neuromyotonia.
    van Sonderen A; Wirtz PW; Verschuuren JJ; Titulaer MJ
    Curr Treat Options Neurol; 2013 Apr; 15(2):224-39. PubMed ID: 23263888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Actual aspects of myasthenia gravis treatment].
    Czapliński A; Radziwiłł AJ; Steck AJ
    Pol Merkur Lekarski; 2003 Mar; 14(81):256-60. PubMed ID: 12914109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Treatment of Myasthenia Gravis.
    Alhaidar MK; Abumurad S; Soliven B; Rezania K
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia Gravis.
    Drachman DB
    Semin Neurol; 2016 Oct; 36(5):419-424. PubMed ID: 27704496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular Myasthenia Gravis.
    Porter NC; Salter BC
    Curr Treat Options Neurol; 2005 Jan; 7(1):79-88. PubMed ID: 15610710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab in severe seronegative juvenile myasthenia gravis: review of the literature.
    Koul R; Al Futaisi A; Abdwani R
    Pediatr Neurol; 2012 Sep; 47(3):209-12. PubMed ID: 22883288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis.
    Silvestri NJ; Wolfe GI
    Semin Neurol; 2012 Jul; 32(3):215-26. PubMed ID: 23117946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis. Pathogenesis and current concepts in management.
    Havard CW; Scadding GK
    Drugs; 1983 Aug; 26(2):174-84. PubMed ID: 6884241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in the treatment of myasthenia gravis.
    Gold R; Hohlfeld R; Toyka KV
    Ther Adv Neurol Disord; 2008 Sep; 1(2):36-51. PubMed ID: 21180568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of refractory generalized myasthenia gravis with rituximab.
    Lebrun C; Bourg V; Tieulie N; Thomas P
    Eur J Neurol; 2009 Feb; 16(2):246-50. PubMed ID: 19146644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Myasthenia Gravis in the Aged.
    Alkhawajah NM; Oger J
    Drugs Aging; 2015 Sep; 32(9):689-97. PubMed ID: 26363907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroids and immunosuppressant drugs in myasthenia gravis.
    Sathasivam S
    Nat Clin Pract Neurol; 2008 Jun; 4(6):317-27. PubMed ID: 18493241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.